CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Low bargaining power of supplier
3.3.2 Moderate bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Moderate threat of substitute
3.3.5 Moderate competitive rivalry
3.4 Government regulations
3.5 Research & Analysis
3.5.1 Clinical trials of research studies conducted for analgesics market
3.6 Market dynamics
3.6.1 Drivers
3.6.2 Restraints
3.6.3 Opportunities
CHAPTER 4 WORLD ANALGESICS MARKET, BY TYPE, 2015-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Non-opioids
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Opioids
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
CHAPTER 5 WORLD ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022
5.1 Oral route
5.1.1 Market size and forecast
5.2 Intravenous route
5.2.1 Market size and forecast
5.3 Rectal route
5.3.1 Market size and forecast
5.4 Transdermal route
5.4.1 Market size and forecast
5.5 Topical route
5.5.1 Market size and forecast
CHAPTER 6 WORLD ANALGESICS MARKET BY GEOGRAPHY, 2015-2022
6.1 North America
6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast
6.1.4 United states
6.1.4.1 Market size and forecast
6.1.5 Canada
6.1.5.1 Market size and forecast
6.1.6 Mexico
6.1.6.1 Market size and forecast
6.2 Europe
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 United Kingdom
6.2.4.1 Market size and forecast
6.2.5 Germany
6.2.5.1 Market size and forecast
6.2.6 Spain
6.2.6.1 Market size and forecast
6.2.7 Sweden
6.2.7.1 Market size and forecast
6.2.8 France
6.2.8.1 Market size and forecast
6.2.9 Russia
6.2.9.1 Market size and forecast
6.2.10 Denmark
6.2.10.1 Market size and forecast
6.2.11 Rest of Europe
6.2.11.1 Market size and forecast
6.3 Asia Pacific
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Japan
6.3.4.1 Market size and forecast
6.3.5 China
6.3.5.1 Market size and forecast
6.3.6 India
6.3.6.1 Market size and forecast
6.3.7 Australia
6.3.7.1 Market size and forecast
6.3.8 Indonesia
6.3.8.1 Market size and forecast
6.3.9 Rest of Asia-Pacific
6.3.9.1 Market size and forecast
6.4 LAMEA
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Brazil
6.4.4.1 Market size and forecast
6.4.5 Venezuela
6.4.5.1 Market size and forecast
6.4.6 Chile
6.4.6.1 Market size and forecast
6.4.7 Saudi Arabia
6.4.7.1 Market size and forecast
6.4.8 United Arab Emirates (UAE)
6.4.8.1 Market size and forecast
6.4.9 Morocco
6.4.9.1 Market size and forecast
6.4.10 Kenya
6.4.10.1 Market size and forecast
6.4.11 Nigeria
6.4.11.1 Market size and forecast
6.4.12 Rest ofLAMEA
6.4.12.1 Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Bayer AG
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Business performance
7.1.5 Key Strategic moves and developments
7.1.6 SWOT analysis
7.2 Novartis AG
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Business performance
7.2.5 Key strategic moves and development
7.2.6 SWOT analysis
7.3 GlaxoSmithKline PLC
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategies move and development
7.3.6 SWOT Analysis
7.4 Pfizer Inc.
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Strategic moves and developments
7.4.6 SWOT analysis
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves and developments
7.5.6 SWOT analysis
7.6 Reckitt Benckiser (RB)
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 SWOT analysis
7.7 Endo Pharmaceuticals
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key strategic moves and developments
7.7.6 SWOT analysis
7.8 Bristol-Myers Squibb
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategic moves and developments
7.8.5 SWOT analysis
7.9 Eli Lilly and Company
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key strategic moves and developments
7.9.6 SWOT analysis
7.10 Sanofi
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating business segments
7.10.4 Business performance
7.10.5 Strategic moves and developments
7.10.6 SWOT analysis